Search results for "Cancer"

showing 10 items of 11546 documents

Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.

2020

Abstract Background Muscle-invasive bladder cancer (MIBC) is the second most common genitourinary malignancy, and is associated with high morbidity and mortality. Recently, molecular subtypes of MIBC have been identified, which have important clinical implications. Objective In the current study, we tried to predict the molecular subtype of MIBC samples from conventional histomorphology alone using deep learning. Design, setting, and participants Two cohorts of patients with MIBC were used: (1) The Cancer Genome Atlas Urothelial Bladder Carcinoma dataset including 407 patients and (2) our own cohort including 16 patients with treatment-naive, primary resected MIBC. This resulted in a total …

medicine.medical_specialtyUrology030232 urology & nephrologyH&E stainDiseaseMalignancy03 medical and health sciences0302 clinical medicineDeep LearningCarcinomamedicineHumansNeoplasm InvasivenessBladder cancerReceiver operating characteristicbusiness.industryDeep learningmedicine.diseaseMolecular Diagnostic TechniquesUrinary Bladder Neoplasms030220 oncology & carcinogenesisHistopathologyArtificial intelligenceRadiologybusinessForecastingEuropean urology
researchProduct

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

2003

Abstract Objective: Pathologists play a pivotal role in the diagnosis and in the report of the pathological features related to prognosis. Methods: To meet these endpoints, the following issues must be accomplished: adequate information about the patient history, proper handling of the specimens, identification of the reliable histopathological techniques necessary to reach the more detailed diagnostic information and evaluate the prognostic variables, and a standardized pathological report. Results: Recent efforts to standardize the histopathological evaluation have generated significant confusion among the urological and pathological communities as well. No consensus has been achieved abo…

medicine.medical_specialtyUrologyBiopsySpecimen HandlingmedicineHumansMedical historyKidney PelvisPhysician's RoleGrading (tumors)Neoplasm StagingBladder cancerPathology Clinicalbusiness.industryUreteral NeoplasmsAnatomical pathologyProfessional PracticePathology Reportmedicine.diseasePrognosisKidney NeoplasmsSurgerySquamous carcinomamedicine.anatomical_structureEpidermoid carcinomaUrinary Bladder NeoplasmsRadiologybusinessRenal pelvisEuropean urology
researchProduct

Continent diversion with the Mainz pouch.

1996

From 1983 until July 1994, 561 patients in 2 urology departments (Mainz and Wuppertal) underwent a Mainz pouch 1 procedure. The Mainz pouch 1 was used for bladder augmentation in 60 patients, for orthotopic bladder substitution in 61 patients, and for continent cutaneous urinary diversion in 440 patients. In the group of continent cutaneous urinary diversion, the continence mechanism applied was an ileal intussusception nipple in 270 patients, an appendix stoma in 146 patients, a submucosal seromuscular bowel-flap tube in 14 patients, and a submucosal full-thickness bowel-flap tube in 10 patients. Indications for urinary diversion were bladder cancer in 339 patients, anatomical or functiona…

medicine.medical_specialtyUrologyUrinary systemmedicine.medical_treatmentUrinary LeakagePostoperative ComplicationsIleumRisk FactorsmedicineHumansCecumBladder cancerbusiness.industryUrinary retentionUrinary diversionUrinary Reservoirs Continentmedicine.diseasePrognosisAppendixSurgerySurvival Ratemedicine.anatomical_structureBladder augmentationEvaluation Studies as TopicPouchmedicine.symptombusinessFollow-Up StudiesWorld journal of urology
researchProduct

Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell…

1996

Objectives. To evaluate a selected population of 50 consecutive patients with primary T1, G3 bladder transitional cell carcinoma in the absence of carcinoma in situ (Tis) treated with a bladder-sparing approach. Methods. Between January 1983 and December 1992, all patients were treated by transurethral resection (TUR) plus adjuvant intravesical chemotherapy over 1 year. In most cases, doxorubicin, epirubicin, and mitomycin were used alone or in combination. Results. At a mean follow-up period of 52 months (range, 18 to 126), 16 of 50 patients (32%) showed a recurrent superficial tumor. The recurrent lesion was of Stage T1 in 11 (22%) cases, but was a T1, G3 tumor only in 5 cases (10%). In 2…

medicine.medical_specialtyUrologymedicine.medical_treatmentPopulationAntineoplastic AgentsMitomycinsSettore MED/24 - UrologiaCystectomyUrethraCarcinomamedicineHumansBACILLUS CALMETTE-GUERINeducationEpirubicinNeoplasm StagingCarcinoma Transitional Celleducation.field_of_studyUrinary bladderBladder cancerbusiness.industryCarcinoma in situmedicine.diseaseCombined Modality TherapyCANCERSurgeryAdministration Intravesicalmedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsChemotherapy AdjuvantDoxorubicinSurgical Procedures OperativeNeoplasm Recurrence LocalbusinessFollow-Up StudiesEpirubicinmedicine.drugUrology
researchProduct

Sentinel lymph node imaging in urologic oncology

2018

Lymph node (LN) metastases in urological malignancies correlate with poor oncological outcomes. Accurate LN staging is of great importance since patients can benefit from an optimal staging, accordingly aligned therapy and more radical treatments. Current conventional cross-sectional imaging modalities [e.g., computed tomography (CT) and magnetic resonance imaging (MRI)] are not accurate enough to reliably detect early LN metastases as they rely on size criteria. Radical lymphadenectomy, the surgical removal of regional LNs, is the gold standard of invasive LN staging. The LN dissection is guided by anatomic considerations of lymphatic drainage pathways of the primary tumor. Selection of pa…

medicine.medical_specialtyUrologymedicine.medical_treatmentSentinel lymph node030232 urology & nephrologyReview Articleurologic cancer03 medical and health sciences0302 clinical medicineSentinel lymph node (sentinel LN)medicinePenile cancerLymph nodebusiness.industryMelanomastagingSentinel nodemedicine.diseasePrimary tumormedicine.anatomical_structureReproductive Medicine030220 oncology & carcinogenesisLymphadenectomyRadiologybusinessGamma probeTranslational Andrology and Urology
researchProduct

ICUD-EAU International Consultation on Bladder Cancer 2012: Non–Muscle-Invasive Urothelial Carcinoma of the Bladder

2012

Item does not contain fulltext CONTEXT: Our aim was to present a summary of the Second International Consultation on Bladder Cancer recommendations on the diagnosis and treatment options for non-muscle-invasive urothelial cancer of the bladder (NMIBC) using an evidence-based approach. OBJECTIVE: To critically review the recent data on the management of NMIBC to arrive at a general consensus. EVIDENCE ACQUISITION: A detailed Medline analysis was performed for original articles addressing the treatment of NMIBC with regard to diagnosis, surgery, intravesical chemotherapy, and follow-up. Proceedings from the last 5 yr of major conferences were also searched. EVIDENCE SYNTHESIS: The major findi…

medicine.medical_specialtyUrologymedicine.medical_treatmentUrologyMEDLINEAntineoplastic AgentsContext (language use)Aetiology screening and detection [ONCOL 5]CystectomyQuality of Care [ONCOL 4]Molecular epidemiology [NCEBP 1]CystectomyTranslational research [ONCOL 3]medicineHumansNeoplasm InvasivenessProspective cohort studyNeoplasm StagingBladder cancermedicine.diagnostic_testbusiness.industryGeneral surgeryCarcinoma in situCystoscopymedicine.diseaseAdministration IntravesicalTreatment OutcomeUrinary Bladder NeoplasmsBCG VaccineDisease ProgressionNeoplasm GradingNeoplasm Recurrence LocalUrotheliumbusinessIntravesical chemotherapyCarcinoma in SituEuropean Urology
researchProduct

Maxillofacial metastasis of genitourinary origin. A report of 3 cases and review of the literature.

2010

Introduction: The maxillofacial region can harbour a wide range of primary tumours, as well as secondary tumours spreading from distant sites. Rare, though nevertheless important among the latter are genitourinary tumours, such as clear cell renal carcinoma and cervical cancer. Diagnosis of the maxillofacial metastasis sometimes precedes that of the original site, though in other cases the metastasis may arise many years after treatment of the primary tumour. Case report: We present three cases of maxillofacial metastasis of genitourinary tumours, two clear cell renal ade-nocarcinoma and squamous cell carcinoma of the uterine cervix. The patients were referred our hospital service for diagn…

medicine.medical_specialtyUterine Cervical NeoplasmsDiseaseMetastasismedicineHumansGeneral DentistryCarcinoma Renal CellCervical cancerMaxillary NeoplasmsGenitourinary systemMaxillary Neoplasmsbusiness.industryReview-ArticleMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryUterine cervixOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellSurgeryFemaleRadiologyOral SurgerybusinessClear cellAfter treatmentMedicina oral, patologia oral y cirugia bucal
researchProduct

Pure anti-oestrogens

2000

Pure anti-oestrogens are a group of at least five new compounds which are able to antagonize the effects of oestrogen in all tissues and species studied. The mechanism by which the pure anti-oestrogens produce their effects remains in question, but all of them are competitive antagonists of the oestrogen receptors and, moreover, have been proposed to block the shuttling of oestrogen receptors into the cell nucleus. When studied in vitro, these compounds are able to block the oestrogen-stimulated growth of breast cancer cells. In animals, their ability to block the effects of oestrogen on breast, uterus, bone, cardiovascular system and other reproductive-associated tissues has been demonstra…

medicine.medical_specialtyUterusBreast NeoplasmsBreast cancerInternal medicineAnimalsHumansMedicineIn patientskin and connective tissue diseasesReceptorFulvestrantEstradiolMolecular Structurebusiness.industryEstrogen AntagonistsObstetrics and Gynecologymedicine.diseaseIn vitroClinical trialEndocrinologymedicine.anatomical_structureReproductive MedicineCancer researchFemaleBreast cancer cellsbusinessTamoxifenmedicine.drugHuman Reproduction Update
researchProduct

ASO Authors Reflections: Vaginectomy as Surgical Treatment of Recurrent Cervical Cancer

2020

medicine.medical_specialtyVaginal Neoplasmsmedicine.medical_treatmentMEDLINERecurrent cervical cancerUterine Cervical NeoplasmsColpotomyHysterectomyVaginectomyColpotomy; Female; Humans; Hysterectomy; Neoplasm Recurrence Local; Pregnancy; Uterine Cervical Neoplasms; Vaginal NeoplasmsNeoplasm RecurrenceSurgical oncologyPregnancymedicineHumansSurgical treatmentPregnancyHysterectomybusiness.industryGeneral surgeryVaginectomymedicine.diseaseOncologySurgeryFemaleNeoplasm Recurrence Localbusiness
researchProduct

Estimation of serum lipids in patients with Oral Submucous Fibrosis in India

2014

Objectives: Oral submucous fibrosis (OSMF) is the most prevalent precancerous condition in India. Low levels of lipids serves as a marker and prognostic indicator in the early detection of oral precancerous and cancerous states. In spite of the high prevalence and its potential to undergo malignant transformation, this condition has not widely been investigated with respect to the serum lipid levels. In the present study, an attempt was made to analyze the complete serum lipid profile, total cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL) choleste - rol, low density lipoprotein (LDL) cholesterol and very low density lipoprotein (VLDL) cholesterol in OSMF and controls. M…

medicine.medical_specialtyVery low-density lipoproteinBlood lipidsOdontologíaGastroenterologychemistry.chemical_compoundHigh-density lipoproteinInternal medicinemedicineGeneral DentistryOral Medicine and Pathologymedicine.diagnostic_testCholesterolbusiness.industryResearchmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludPrecancerous conditionEndocrinologychemistryOral submucous fibrosisLow-density lipoproteinUNESCO::CIENCIAS MÉDICASlipids (amino acids peptides and proteins)businessLipid profile
researchProduct